Pfizer Inc.: DCF model
A discounted-cash-flow model filled in from Pfizer Inc.'s filings as reported. Change any assumption; the values follow at once.
A tool for your own analysis, not investment advice. It does arithmetic on the figures the company filed and on assumptions you choose; it does not forecast, and the result is only as good as those assumptions. Every formula is on the methodology page.
Market price USD 29.95 on Oct 30, 2026: Closing price the SEC publishes with its fails-to-deliver data (PFE).
Assumptions: Base case
Change any figure; the values follow at once.
Revenue and margins
From the filings10-K filed Feb 26, 2026
The years between change on a straight line.
From the filingsThe first year starts at Revenue growth a year from FY2022 to FY2025 (3 years), held within -10% to 25%: -14.80% a year; the years after are your assumption.
The years between change on a straight line.
From the filingsAverage operating margin, FY2023–FY2025: 11.56%; the years ahead are your assumption.
Tax and reinvestment
From the filingsIncome tax over income before tax, FY2023–FY2025, held within 0% to 40%
From the filingsAverage share of revenue, FY2023–FY2025
From the filingsAverage share of revenue, FY2023–FY2025
From the filingsAverage operating working capital (current assets less cash and short-term investments, less current liabilities other than debt) as a share of revenue, FY2023–FY2025
Discount rate
Your assumption1.0 to start with
Your assumption5% to start with
From the filingsInterest expense of FY2025 over its average debt, held between the risk-free rate and 8 points above it
From the filingsDebt over debt plus market value on Oct 30, 2026
After the last year
Your assumptionImplies 12.5× the last year's EBITDA.
From value to shares (every case)
Balance sheet of Q3FY2026, Sep 27, 2026 · 10-Q filed Nov 3, 2026
From the filings
From the filings
From the filings
From the filings
Your assumption
From the filingsdiluted, weighted average, Q3FY2026 · 10-Q filed Nov 3, 2026
The three cases
Base case: value per share
Discount rate 8.81%; long-run growth 2.50%. Values as at the end of FY2025.
| Present value of the 5 projected years | USD 35.1 B |
|---|---|
| Present value after the last year73% of the business's value | USD 94.1 B |
| Enterprise value (the whole business) | USD 129.2 B |
| Less debt | USD 62.7 B |
| Plus cash and short-term investments | USD 10.9 B |
| Less minority interests | USD 299 M |
| Equity value (the shareholders') | USD 77.1 B |
| Divided by shares (millions) | 5,751 |
| Value per share | USD 13.41 |
Value per share
USD 13.41
55.2% below the price
Price USD 29.95 on Oct 30, 2026
Base case: year by year
Millions of USD. The FY2025 column is as reported; the years after are projected. Tax, capital spending and working capital are signed as they add to (+) or take from (−) free cash flow.
| USD millions | FY2025reported | FY2026projected | FY2027projected | FY2028projected | FY2029projected | FY2030projected |
|---|---|---|---|---|---|---|
| Revenue | 62,579 | 56,321 | 52,452 | 50,485 | 50,172 | 51,426 |
| Growth | -1.6% | -10.0% | -6.9% | -3.8% | -0.6% | 2.5% |
| Operating income (EBIT) | 9,588 | 6,511 | 6,063 | 5,836 | 5,800 | 5,945 |
| Operating margin | 15.3% | 11.6% | 11.6% | 11.6% | 11.6% | 11.6% |
| Tax on operating income | −0 | −0 | −0 | −0 | −0 | |
| Depreciation and amortisation | 6,592 | 6,032 | 5,618 | 5,407 | 5,373 | 5,508 |
| Capital spending | −2,629 | −2,878 | −2,680 | −2,580 | −2,564 | −2,628 |
| Change in working capital | −11 | −7 | −3.5 | −0.6 | 2.3 | |
| Free cash flow to the firm | 17,193 | 9,653 | 8,994 | 8,660 | 8,609 | 8,827 |
| Discount factor | 0.9191 | 0.8447 | 0.7763 | 0.7135 | 0.6557 | |
| Present value | 8,872 | 7,597 | 6,722 | 6,142 | 5,788 |
Base case: sensitivity
How the value per share moves when one pair of figures changes and the rest stay as they are.
Discount rate and long-run growth
Value per share in USD; your figures in the outlined middle; green at or above the market price, red below it.
| Discount rate ↓ · Long-run growth → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 6.81% | 18.5 | 20.81 | 23.66 | 27.26 | 31.94 |
| 7.81% | 14.18 | 15.73 | 17.57 | 19.8 | 22.54 |
| 8.81% | 11.04 | 12.14 | 13.41 | 14.91 | 16.69 |
| 9.81% | 8.65 | 9.47 | 10.39 | 11.45 | 12.68 |
| 10.81% | 6.78 | 7.4 | 8.1 | 8.88 | 9.77 |
Revenue growth and operating margin
Value per share in USD; your figures in the outlined middle; green at or above the market price, red below it.
| Growth, every year ↓ · Margin, every year → | −4 pt | −2 pt | ±0 pt | +2 pt | +4 pt |
|---|---|---|---|---|---|
| −4 pt | 5.24 | 7.41 | 9.58 | 11.76 | 13.93 |
| −2 pt | 6.65 | 9.04 | 11.42 | 13.81 | 16.2 |
| ±0 pt | 8.18 | 10.8 | 13.41 | 16.03 | 18.65 |
| +2 pt | 9.83 | 12.7 | 15.57 | 18.44 | 21.3 |
| +4 pt | 11.61 | 14.75 | 17.89 | 21.03 | 24.17 |
Where the figures come from
The statements as reported, in millions of USD; hover a figure for its filing.
| USD millions | FY2025to Dec 31, 2025 | FY2024to Dec 31, 2024 | FY2023to Dec 31, 2023 | FY2022to Dec 31, 2022 | FY2021to Dec 31, 2021 | FY2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | 62,579 | 63,627 | 59,553 | 101,175 | 81,288 | 41,651 |
| Growth | -1.6% | 6.8% | -41.1% | 24.5% | 95.2% | — |
| Operating income | 9,588 | 10,569 | 1,643 | 35,716 | 25,566 | 8,412 |
| Operating margin | 15.3% | 16.6% | 2.8% | 35.3% | 31.5% | 20.2% |
| Effective tax rate | -3.5% | -0.3% | -105.4% | 9.6% | 7.6% | 5.3% |
| D&A, % of revenue | 10.5% | 11.0% | 10.6% | 5.0% | 6.4% | 11.2% |
| Capital spending, % of revenue | 4.2% | 4.6% | 6.6% | 3.2% | 3.3% | 5.3% |
| Working capital, % of revenue | -2.0% | 3.7% | -2.3% | -7.0% | -5.8% | -0.9% |
| Free cash flow to the firm | 17,193 | 10,924 | −1,703 | 36,519 | 30,420 | — |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
- Operating income is not tagged in some of these filings: it is worked out as income before tax plus interest expense less interest income.
- From the filings: revenue, margins, tax rate, depreciation, capital spending and working capital (fiscal years above), debt, cash, leases and minority interests (balance sheet of Q3FY2026), and the share count (Q3FY2026).
- Market data: US Treasury daily par yield curve, 10-year (Nov 13, 2026); Market price USD 29.95 on Oct 30, 2026: Closing price the SEC publishes with its fails-to-deliver data (PFE).
- Your assumptions: the growth path and margins ahead, beta, the equity risk premium, long-run growth or the exit multiple, and the weights of the cases. How each figure is worked out: methodology.